2007
DOI: 10.1016/j.cca.2007.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Screening and diagnosis of congenital disorders of glycosylation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
58
0
3

Year Published

2009
2009
2014
2014

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 72 publications
(61 citation statements)
references
References 133 publications
0
58
0
3
Order By: Relevance
“…However, transferrin does not detect all N-glycosylation defects (3) and does not pinpoint the defective gene (4). More important, there is currently no corresponding indicator of reduced glycosylation in patient cells.…”
Section: Congenital Disorders Of Glycosylation (Cdg)mentioning
confidence: 99%
“…However, transferrin does not detect all N-glycosylation defects (3) and does not pinpoint the defective gene (4). More important, there is currently no corresponding indicator of reduced glycosylation in patient cells.…”
Section: Congenital Disorders Of Glycosylation (Cdg)mentioning
confidence: 99%
“…and human disease states (e.g., cancer; congenital disorders of glycosylation; neurodegenerative disorders, etc.). [6][7][8][9][10][11][12][13][14][15][16][17] While protein glycosylation analyses are oen carried out with either a "glycocentric" (i.e., compositional and structural analysis of glycans released from glycoproteins) or a "proteocentric" (i.e., identication of deglycosylated glycoproteins with indirect glycosylation site localization) outlook, the loss of molecular detail imposed by glycan release limits the specicity and potential for biological resolution that can be furnished by such analyses. 18 In order to map specic oligosaccharide structures to their corresponding sites of protein attachment, the analytical scheme must preserve the oligosaccharide-polypeptide connectivity until such a time that the chosen approach can characterize the linkage.…”
Section: Introductionmentioning
confidence: 99%
“…LLO (lipid-linked oligosaccharides) analysis of fibroblasts shows an accumulation of Man9GlcNAc2 (Imbach et al 1999;Burda et al 1998;Marklova and Albahri 2007). A few isolated CDG-ALG6 patients (e.g., patients with the homozygous c.391TT>C, p.Y131H mutation) presented with a normal transferrin and LLO profile (Westphal et al 2003;Miller et al 2011).…”
Section: Introductionmentioning
confidence: 99%